Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in ARTL held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Altshuler Shaham Ltd | 889 | $484K | — | 0.038% | 0.01% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in ARTL — a direct measure of their conviction.
Filings activity in ARTL during Q1 2026, grouped by how each filer changed its position.
Institutions that fully closed their ARTL position in Q1 2026
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 1 | 90% | 15.26% | +12.12 pp | $0M | +386% |
| Q4 2025 | 10 | +25% | 3.14% | +0.85 pp | $0M | +37% |
| Q3 2025 | 8 | +0.0% | 2.29% | 4.65 pp | $0M | 67% |
| Q2 2025 | 8 | 11% | 6.94% | +4.55 pp | $0M | +191% |
| Q1 2025 | 9 | +29% | 2.39% | +1.24 pp | $0M | +107% |
| Q4 2024 | 7 | +17% | 1.15% | +0.34 pp | $0M | +43% |
| Q3 2024 | 6 | 14% | 0.81% | 0.31 pp | $0M | 28% |
| Q2 2024 | 7 | — | 1.12% | — | $0M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying ARTL stock.
Based on Q1 2026 13F filings, institutional ownership of Artelo Biosciences, Inc. stands at 15.3%, held across 1 reporting institutions.
Altshuler Shaham Ltd is the largest reported institutional holder of ARTL, with approximately 889 shares worth $0.00B as of Q1 2026.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of ARTL.
Our composite Smart Money Score for ARTL is 31 out of 100 (Bearish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
1 institutions opened new positions in ARTL during Q1 2026, while 10 fully exited. 0 added to existing positions and 0 trimmed.
ARTL institutional ownership rose by 12.12 percentage points quarter-over-quarter, with a net change of -9 holders.
The top 10 institutions account for 100.0% of all reported 13F value in ARTL, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Artelo Biosciences, Inc. (ARTL) Institutional Ownership